World's Best Scientists 2026 revealed!
JAMA oncology
H-index 106

JAMA oncology

2374-2437

Published by: American Medical Association

https://jamanetwork.com/journals/jamaoncology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 32 1211 852 104

Additional Metrics

Number of Best Scientists*: 1438
Documents by Best Scientists*: 928
Top 100 Ranked Scientists*: 32
SCIMAGO H-index: 193
SCIMAGO SJR: 8.377
Impact Factor: 20.1

Overview

Top Research Topics at JAMA Oncology?

Internal medicine, Oncology, MEDLINE, Cancer and Breast cancer are among the topics commonly tackled in the journal. JAMA Oncology focused on Internal medicine research but expanded to cover Text mining. Some problems in Oncology that were presented in it overlapped with concepts under Survival analysis, Radiation therapy, Prostate cancer and Chemotherapy.

JAMA Oncology explores issues in MEDLINE which can be linked to other research areas like Carcinoma, Family medicine and Intensive care medicine. Most of the works presented in JAMA Oncology deals with Cancer but it intersects with the subject of Cohort study. JAMA Oncology links adjacent topics like Cohort study with Cohort.

Surgery and Proportional hazards model are some topics wherein Hazard ratio research discussed in it have an impact. More specifically, the research on Randomized controlled trial in JAMA Oncology is related to Clinical endpoint. The work tackled in it goes beyond the discipline of Clinical trial as it also encompasses Adverse effect.

  • Internal medicine (53.00%)
  • Oncology (38.90%)
  • MEDLINE (27.81%)

What are the most cited papers published in the journal?

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study (2992 citations)
  • The Global Burden of Cancer 2013 (1826 citations)
  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 (1522 citations)

Research areas of the most cited articles at JAMA Oncology:

The journal papers focus largely on the fields of Internal medicine, Oncology, Cancer, Hazard ratio and Clinical trial. The Internal medicine study featured in the published articles draws parallels with the field of Surgery. Oncology research presented in the published articles encompasses a variety of subjects, including Nivolumab and Survival analysis.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

JAMA Oncology explores disciplines such as Internal medicine, MEDLINE, Oncology, Cancer and Randomized controlled trial. Hazard ratio, Breast cancer, Cohort study, Clinical endpoint and Lung cancer studies are all carried out as a component of the study in Internal medicine presented. While MEDLINE is the focus of JAMA Oncology, it also provided insights into the studies of Text mining, Immunotherapy, Family medicine and Intensive care medicine.

The journal explores topics in Oncology which can be helpful for research in disciplines like Pembrolizumab, Ovarian cancer, Radiation therapy and Prostate cancer. It tackles research in various disciplines, including Cancer and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research on Randomized controlled trial featured in JAMA Oncology combines topics in other fields like Interquartile range, Chemotherapy regimen, Quality of life and Clinical trial.

The most cited articles from the last journal are:

  • Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. (67 citations)
  • The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review. (43 citations)
  • Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer. (36 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in JAMA Oncology (based on the number of publications) are:

  • Howard Jack West (37 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Reshma Jagsi (29 papers) published 2 papers at the last edition, 5 less than at the previous edition,
  • Vinay Prasad (28 papers) published 6 papers at the last edition,
  • Edward Giovannucci (22 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Charles S. Fuchs (18 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in JAMA Oncology (based on the number of publications) are:

  • Harvard University (377 papers) published 57 papers at the last edition, 2 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (226 papers) published 34 papers at the last edition, 8 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (223 papers) published 32 papers at the last edition, 2 more than at the previous edition,
  • Brigham and Women's Hospital (147 papers) published 17 papers at the last edition, 1 less than at the previous edition,
  • Mayo Clinic (125 papers) published 25 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.09% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 42.02% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.37% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.16% of all publications and 32.45% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Nursing Requirements and Career Opportunities in Oncology

It's important to note that while discussing research advancements in oncology, it's crucial to acknowledge the human resources, especially the nursing personnel, at the forefront of implementing these research developments. Part of oncology research involves studying and understanding the roles of different medical personnel, their training and licensing requirements and procedures. For instance, in order to contribute effectively to the oncology field as nurses, individuals must meet certain licensure and educational prerequisites.

In the state of Illinois, the nursing license requirements include a specific set of educational qualifications, exams, and applications. Should you be interested, you may wish to review the Illinois nursing license requirements. This link provides accurate and credible information for aspiring oncology nurses regarding state-specific license procurement, thereby encouraging more professionals to join this burgeoning sector.

Nursing personnel can be the bridge between advanced oncological research and practical patient care, and their continuous involvement is indispensable to progress in this field. Career advancement opportunities for oncology nurses are abundant and rewarding, with possibilities for specialization, deepened research involvement, administration roles, and more.

With proper training and the right resources, these healthcare professionals will continue to immensely contribute to the application of findings from key research topics in JAMA Oncology.

Top Publications

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    (2021)
    1934 Citations
  • Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial.

    Thomas Yau;Yoon Koo Kang;Tae You Kim;Anthony B. El-Khoueiry

    (2020)
    1152 Citations
  • Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial

    David A. Reardon;Alba A. Brandes;Antonio Omuro;Paul Mulholland

    (2020)
    1019 Citations
  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Ryan Phillips;William Yue Shi;Matthew Deek;Noura Radwan

    (2020)
    893 Citations
  • Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

    Kohei Shitara;Eric Van Cutsem;Yung Jue Bang;Charles Fuchs

    (2020)
    853 Citations
  • The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

    George W. Sledge;Masakazu Toi;Patrick Neven;Joohyuk Sohn

    (2020)
    815 Citations
  • Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.

    Annette M. Molinaro;Shawn Hervey-Jumper;Ramin A. Morshed;Jacob Young

    (2020)
    640 Citations
  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

    Rita Nanda;Minetta C Liu;Christina Yau;Rebecca Shatsky

    (2020)
    577 Citations
  • Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

    Naiyer A Rizvi;Byoung Chul Cho;Niels Reinmuth;Ki Hyeong Lee

    (2020)
    505 Citations
  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

    Alexander M.M. Eggermont;Michal Kicinski;Christian U. Blank;Mario Mandala

    (2020)
    398 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternative routes, exploring related online degrees and career pathways can be beneficial. Many prospective students start with accessible options like medical assistant classes online with financial aid, which provide foundational skills and valuable certifications without large financial burdens.

Transitioning within healthcare roles is also common. Programs such as the ma to lpn bridge program allow medical assistants to advance toward becoming licensed practical nurses, enhancing both responsibilities and career potential.

For students interested in deeper scientific knowledge, pursuing an online biology bachelor's degree offers a flexible pathway to prepare for medical school or research-oriented roles.

Similarly, aspiring nurses can consider online associate RN programs to become registered nurses while balancing other commitments. These varied options highlight that there are multiple online routes for building a healthcare career alongside or beyond studying Medicine in the USA.

Best Scientists Contributing to This Journal

Recently Published Articles